Leukemia : Impact Factor & More
eISSN: 1476-5551pISSN: 0887-6924
Share this on:
Aims and Scope of Leukemia
Leukemia is a peer-reviewed medical journal published by the Nature Publishing Group. It was established in 1987 by Nicole Muller-Bérat Killman and Sven-Aage Killman, and is currently edited by Professors Andreas Hochhaus and Robert Peter Gale. The journal covers research on all aspects of leukemia and has a 2019 impact factor of 8.665. Less
Key Metrics
CiteScore 
17.6
Eigenfactor
0.01 - 0.05
H-Index
211
Impact Factor
10 - 15
Scite Index
0.91 5-Year SI
SJR
Q1Oncology
SNIP
2.69
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Leukemia
Leukemia Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Leukemia ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Leukemia
A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia.
- 1 Dec 2025
- Leukemia
Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.
- 1 Dec 2025
- Leukemia
Challenges in predicting hydroxyurea resistance and reducing thrombotic risk in polycythemia vera patients: unmasking the limits of its machine learning study.
- 1 Dec 2025
- Leukemia
Correction: Correspondence to "A novel lncRNA SNHG29 regulates EP300-related histone acetylation modification and inhibits FLT3-ITD AML development".
- 21 Nov 2025
- Leukemia
Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.
- 20 Nov 2025
- Leukemia
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.
- 18 Nov 2025
- Leukemia
A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia.
- 1 Dec 2025
- Leukemia
Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.
- 1 Dec 2025
- Leukemia
Challenges in predicting hydroxyurea resistance and reducing thrombotic risk in polycythemia vera patients: unmasking the limits of its machine learning study.
- 1 Dec 2025
- Leukemia
Correction: Correspondence to "A novel lncRNA SNHG29 regulates EP300-related histone acetylation modification and inhibits FLT3-ITD AML development".
- 21 Nov 2025
- Leukemia
Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.
- 20 Nov 2025
- Leukemia
Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint.
- 18 Nov 2025
- Leukemia
FAQs on Leukemia
How long has Leukemia been actively publishing? 
What is the publishing frequency of Leukemia?
How many articles did Leukemia publish last year?
What is the eISSN & pISSN for Leukemia?
What is Citescore for Leukemia?
What is the H Index for Leukemia ?
What is SNIP score for Leukemia?
What is the SJR for Leukemia?
Who is the publisher of Leukemia?
